<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
	<channel>
	<link>http://salesandmarketingnetwork.com/hsmn_newsfeed_public.rss</link>
	<title>HSMN NewsFeed</title>
	<description><![CDATA[Healthcare Sales & Marketing Network NewsFeed]]></description>
	<lastBuildDate>Wed, 10 Mar 2010 16:02:09 CST</lastBuildDate>
	<language>en-us</language>
	<image>
	<title><![CDATA[The Healthcare Sales & Marketing Network]]></title>
	<width>150</width>
	<height>67</height>
	<link>http://salesandmarketingnetwork.com/news.php</link>
	<url>http://salesandmarketingnetwork.com/images/hsmn_logo_150.gif</url>
	</image>
	<item>
		 <title><![CDATA[Smith and Nephew Announces Next Steps in Patent Infringement Litigation]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030335</link>
			<pubDate>Wed, 10 Mar 2010 17:49:47 GMT</pubDate>
			<author><![CDATA[Smith & Nephew]]></author>
		 <description><![CDATA[ST. PETERSBURG, Fla., March 10  (HSMN NewsFeed)  -- The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc. (LSE: SN; NYSE: SNN), notes the decision returned today by a jury in the patent litigation brought by Ki... <br/><font color="red">Devices, Wound Care, Litigation</font><br/><font color="blue">Smith & Nephew, Kinetic Concepts, negative pressure wound therapy</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[KCI Wins Patent Case against Smith and Nephew]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030334</link>
			<pubDate>Wed, 10 Mar 2010 17:44:35 GMT</pubDate>
			<author><![CDATA[Kinetic Concepts]]></author>
		 <description><![CDATA[United States District Court Jury Finds that Smith & Nephew’s Product Infringes Wake Forest Patents Licensed to KCI

SAN ANTONIO--(HSMN NewsFeed)--Kinetic Concepts, Inc. (NYSE: KCI ) today announced that a United States District Court jury has found that... <br/><font color="red">Devices, Wound Care, Litigation</font><br/><font color="blue">Kinetic Concepts, Smith & Nephew, negative pressure wound therapy</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[HyperBranch Medical Technology To Market Surgical Sealants under Adherus Product Name]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030333</link>
			<pubDate>Wed, 10 Mar 2010 17:39:28 GMT</pubDate>
			<author><![CDATA[HyperBranch Medical Technology]]></author>
		 <description><![CDATA[DURHAM, N.C.--(HSMN NewsFeed)--HyperBranch Medical Technology, Inc. announced today that it will begin to market their surgical sealants under a new product identity – Adherus Surgical Sealants.

The Adherus name will soon appear on all Company literatur... <br/><font color="red">Devices, Surgery</font><br/><font color="blue">HyperBranch Medical Technology, Adherus, Surgical Sealant</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Sam Donaldson Named Inaugural Chair of NCCN Foundation Board]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030332</link>
			<pubDate>Wed, 10 Mar 2010 16:12:16 GMT</pubDate>
			<author><![CDATA[National Comprehensive Cancer Network]]></author>
		 <description><![CDATA[The National Comprehensive Cancer Network&reg; (NCCN&reg;) announces that veteran newsman Sam Donaldson has accepted the position of chair of the NCCN Foundation Board of Directors. The NCCN Foundation will seek philanthropic support for programs to benefi... <br/><font color="red">Oncology, Personnel</font><br/><font color="blue">National Comprehensive Cancer Network, NCCN, Patient Guidelines</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[CardioGenics Announces Further Update Regarding Status of Merck Agreement]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030331</link>
			<pubDate>Wed, 10 Mar 2010 16:08:02 GMT</pubDate>
			<author><![CDATA[CardioGenics]]></author>
		 <description><![CDATA[CardioGenics Beads Enter Final Stage of Testing Prior to Commercialization

MISSISSAUGA, Ontario, March 10  (HSMN NewsFeed)  -- CardioGenics Holdings Inc. (OTC Bulletin Board:CGNH.ob ), a developer of technology and products targeting the IVD segment of ... <br/><font color="red">Diagnostics</font><br/><font color="blue">CardioGenics, Merck, paramagnetic beads, immunoassay</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Medtronic Introduces the VERTEX SELECT(R) Reconstruction System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030330</link>
			<pubDate>Wed, 10 Mar 2010 16:03:19 GMT</pubDate>
			<author><![CDATA[Medtronic]]></author>
		 <description><![CDATA[Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation

MEMPHIS, Tenn.--(HSMN NewsFeed)--Medtronic, Inc. (NYSE: MDT ) today announced the U.S. launch of the VERTEX SELECT&reg; Reconstruction System.

When a patient has a spin... <br/><font color="red">Devices, Orthopaedic, Neurosurgery</font><br/><font color="blue">Medtronic, VERTEX SELECT</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Smith and Nephew Orthopaedics Launches Versatile VLP(TM) FOOT Plating System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030329</link>
			<pubDate>Wed, 10 Mar 2010 16:00:39 GMT</pubDate>
			<author><![CDATA[Smith & Nephew]]></author>
		 <description><![CDATA[Variable-angle Locked Plating System Gives Surgeons Solutions for Every Patient Type
prnewswire

MEMPHIS, Tenn., March 10  (HSMN NewsFeed)  -- Smith & Nephew (NYSE: SNN, LSE: SN) Orthopaedics Division today announces the global launch of its VLP™ FOOT V... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">Smith & Nephew, VLP FOOT, Locked Plating System</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cylex(TM) Elects Richard A. Sandberg as Independent Director]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030328</link>
			<pubDate>Wed, 10 Mar 2010 15:57:28 GMT</pubDate>
			<author><![CDATA[Cylex]]></author>
		 <description><![CDATA[New Director Brings Significant Expertise in Developing Medical Diagnostic Companies

COLUMBIA, Md., March 10  (HSMN NewsFeed)  -- Cylex announced today the election of Richard A. (&quot;Dick&quot;) Sandberg, founder of DIANON Systems, as an independent ... <br/><font color="red">Diagnostics, Personnel</font><br/><font color="blue">Cylex, ImmuKnow, cell-mediated immunity</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[RecoverCare Enhances Management Team]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030327</link>
			<pubDate>Wed, 10 Mar 2010 15:54:19 GMT</pubDate>
			<author><![CDATA[RecoverCare]]></author>
		 <description><![CDATA[Kevin McKim Appointed President

Ryan Schmidt to Join Company as Chief Operating Officer

LOUISVILLE, Ky., March 10  (HSMN NewsFeed)  -- RecoverCare, LLC, a leading distributor of wound care and bariatric equipment and solutions to the acute and long t... <br/><font color="red">Devices, Wound Care, Personnel</font><br/><font color="blue">RecoverCare</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cerulean Pharma Inc. Appoints Two Senior Executives to Management Team]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030326</link>
			<pubDate>Wed, 10 Mar 2010 15:49:06 GMT</pubDate>
			<author><![CDATA[Cerulean Pharma]]></author>
		 <description><![CDATA[Company Appoints John Ryan, Ph.D., M.D., to serve as Senior Vice President, Chief Medical Officer, and Karen Roberts to serve as Senior Vice President, Finance and Administration

CAMBRIDGE, Mass.--(HSMN NewsFeed)--Cerulean Pharma Inc., a biopharmaceutic... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue">Cerulean Pharma</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Oculus Innovative Sciences Receives First FDA Clearance for Microcyn®-Based HydroGel for Dermatology Market with Claims Including Reduction of Itch and Pain Relief]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030325</link>
			<pubDate>Wed, 10 Mar 2010 15:47:03 GMT</pubDate>
			<author><![CDATA[Oculus Innovative Sciences]]></author>
		 <description><![CDATA[U.S. Launch Targeted for April 2010

Product Has Received Medicare Reimbursement

PETALUMA, Calif.--(HSMN NewsFeed)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS ), a commercial medical technology company that develops, manufactures and markets a fam... <br/><font color="red">Devices, Wound Care, Dermatology, FDA</font><br/><font color="blue">Oculus Innovative Sciences, Microcyn, Wound HydroGel</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Unilife and Stason Pharmaceuticals Sign Asian Distribution Agreement for the Unitract(TM) 1mL Safety Syringe]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030324</link>
			<pubDate>Wed, 10 Mar 2010 15:44:14 GMT</pubDate>
			<author><![CDATA[Unilife]]></author>
		 <description><![CDATA[Initial order for 1 million units of the Unitract(TM) 1mL Syringe

LEWISBERRY, Pa., March 10  (HSMN NewsFeed)  -- Unilife Corporation (&quot;Unilife&quot; or &quot;Company&quot;) (Nasdaq: UNIS; ASX: UNS) today announced that it has signed an exclusive fi... <br/><font color="red">Devices, Distribution</font><br/><font color="blue">Unilife, Stason Pharmaceuticals, Unitract, safety syringe</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Watson Announces Actos(R) Patent Challenge Settlement]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030323</link>
			<pubDate>Wed, 10 Mar 2010 15:40:18 GMT</pubDate>
			<author><![CDATA[Watson Pharmaceuticals]]></author>
		 <description><![CDATA[MORRISTOWN, N.J., March 10  (HSMN NewsFeed)  -- Watson Pharmaceuticals, Inc. (NYSE:WPI ), today announced that it has reached a settlement agreement with Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America resolving outstanding p... <br/><font color="red">Biopharmaceuticals, Generics, Litigation</font><br/><font color="blue">Watson Pharmaceuticals, Takeda Pharmaceutical, Actos, Pioglitazone</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[RTI Biologics Launches Two Biologic Implants at Orthopaedic Surgeon Annual Meeting]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030322</link>
			<pubDate>Wed, 10 Mar 2010 15:38:12 GMT</pubDate>
			<author><![CDATA[RTI Biologics]]></author>
		 <description><![CDATA[ALACHUA, Fla.--(HSMN NewsFeed)--RTI Biologics Inc. (RTI) (Nasdaq: RTIX ), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries at th... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">RTI Biologics, BTB Select, BioCAP Select, allograft</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030321</link>
			<pubDate>Wed, 10 Mar 2010 15:35:13 GMT</pubDate>
			<author><![CDATA[Cytokinetics]]></author>
		 <description><![CDATA[SOUTH SAN FRANCISCO, CA - (HSMN NewsFeed) - Cytokinetics, Incorporated (NASDAQ:CYTK ) announced today that its fast skeletal muscle troponin activator, CK-2017357, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for ... <br/><font color="red">Biopharmaceuticals, Neurology, FDA</font><br/><font color="blue">Cytokinetics, CK-2017357, amyotrophic lateral sclerosis</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030320</link>
			<pubDate>Wed, 10 Mar 2010 15:14:58 GMT</pubDate>
			<author><![CDATA[Abbott]]></author>
		 <description><![CDATA[Premium Lens Provides Medicare Beneficiaries With New Option

ABBOTT PARK, Ill., March 10  (HSMN NewsFeed)  -- Abbott (NYSE:ABT ) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS&reg; Multifocal 1-Piece intr... <br/><font color="red">Devices, Ophthalmology, FDA</font><br/><font color="blue">Abbott, TECNIS, Multifocal intraocular lens, intraocular lens</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[New Easy-To-Use Knotless Arthroscopic Device Provides Surgeons With Full Control Over Suture Tension; Critical Element In Procedure]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030319</link>
			<pubDate>Wed, 10 Mar 2010 15:12:04 GMT</pubDate>
			<author><![CDATA[Smith & Nephew]]></author>
		 <description><![CDATA[ANDOVER, Mass., March 10  (HSMN NewsFeed)  -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced the launch of the BIORAPTOR™ Knotless Suture Anchor, a device used to repair a torn labrum in the hip and shoulder.  The anchor is among ... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">Smith & Nephew, BIORAPTOR, Knotless Suture Anchor</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[SANUWAVE Health's Technology Shown to Successfully Treat Nonunion Fractures of the Tibia]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030318</link>
			<pubDate>Wed, 10 Mar 2010 15:10:10 GMT</pubDate>
			<author><![CDATA[ANUWAVE Health]]></author>
		 <description><![CDATA[Expects To Introduce New Commercial Product in Europe in the Second Quarter

ALPHARETTA, Ga.--(HSMN NewsFeed)--SANUWAVE Health, Inc., (OTC BB: SNWV ) (www.sanuwave.com), an emerging medical technology company focused on the development and commercializat... <br/><font color="red">Devices, Orthopaedic, Regenerative Medicine</font><br/><font color="blue">ANUWAVE Health, Ossatron, Extracorporeal Shock Wave</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Integra LifeSciences Announces the Release of the Integra(TM) Total Wrist Fusion System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030317</link>
			<pubDate>Wed, 10 Mar 2010 11:06:39 GMT</pubDate>
			<author><![CDATA[Integra LifeSciences]]></author>
		 <description><![CDATA[PLAINSBORO, N.J., March 10, 2010 --(HSMN NewsFeed) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) announced today the release of the Integra(TM) Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation o... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">Integra LifeSciences, Total Wrist Fusion System</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Integra LifeSciences Launches Integra Mozaik(TM) Moldable Morsels for Bone Grafting Procedures]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030316</link>
			<pubDate>Wed, 10 Mar 2010 11:04:00 GMT</pubDate>
			<author><![CDATA[Integra LifeSciences]]></author>
		 <description><![CDATA[PLAINSBORO, N.J., March 10, 2010 --(HSMN NewsFeed) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART ) announced today the introduction of Integra Mozaik(TM) Moldable Morsels bone void filler, which will be available in four sizes. Integra Mozaik(T... <br/><font color="red">Devices, Neurosurgery, Orthopaedic</font><br/><font color="blue">Integra LifeSciences, Mozaik, Moldable Morsels, bone void filler</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Diamyd Medical: Diamyd US Phase III Study Well under Way]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030315</link>
			<pubDate>Wed, 10 Mar 2010 10:59:51 GMT</pubDate>
			<author><![CDATA[Diamyd Medical]]></author>
		 <description><![CDATA[STOCKHOLM--(HSMN NewsFeed)--Diamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY ) announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company’s lead drug candi... <br/><font color="red">Biopharmaceuticals, Endocrinology</font><br/><font color="blue">Diamyd Medical, DiaPrevent, Diamyd, diabetes</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030314</link>
			<pubDate>Tue, 09 Mar 2010 20:00:27 GMT</pubDate>
			<author><![CDATA[Orthopaedic Synergy]]></author>
		 <description><![CDATA[EAST TAUNTON, Mass., March 9  (HSMN NewsFeed)  -- Orthopaedic Synergy, Inc., is pleased to announce that it has entered into a letter of intent and period of exclusivity to acquire Praxim, SA of France.   

&quot;The acquisition of Praxim SA will represe... <br/><font color="red">Devices, Orthopaedic, Mergers & Acquisitions</font><br/><font color="blue">Orthopaedic Synergy, Praxim</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[ETEX Corporation Announces FDA Clearance and Launch of Carrigen(R) Porous Bone Substitute Material]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030313</link>
			<pubDate>Tue, 09 Mar 2010 19:57:23 GMT</pubDate>
			<author><![CDATA[ETEX Corp]]></author>
		 <description><![CDATA[Carrigen(R) Porous Bone Substitute Material - The First Hard Setting, Highly Porous Bone Graft Substitute

CAMBRIDGE, Mass., March 9  (HSMN NewsFeed)  --ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510(k) c... <br/><font color="red">Devices, Orthopaedic, FDA</font><br/><font color="blue">ETEX Corp, CarriGen, Bone Substitute</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Positron Corporation Cites JACR Study That Reports a 737% Growth Rate in PET among 5 Speciality Groups Including Cardiology]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030312</link>
			<pubDate>Tue, 09 Mar 2010 19:43:20 GMT</pubDate>
			<author><![CDATA[Positron Corp]]></author>
		 <description><![CDATA[INDIANAPOLIS--(HSMN NewsFeed)--Positron Corporation (OTCBB:POSC ). The growth rate among nonradiologists who own or lease PET equipment was far higher than radiologists between 2002 and 2007, according to a study published in the March issue of the Journal... <br/><font color="red">Devices, Radiology, Oncology, Cardiology</font><br/><font color="blue">Positron Corp, positron emission tomography, PET imaging</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030311</link>
			<pubDate>Tue, 09 Mar 2010 19:38:48 GMT</pubDate>
			<author><![CDATA[Medifocus]]></author>
		 <description><![CDATA[VANCOUVER, British Columbia--(HSMN NewsFeed)--Medifocus Inc. (OTC:MDFZF.PK and TSXV:MFS) is pleased to announce that it has received from the Food and Drug Administration (FDA) an Investigational Device Exemption (IDE) approval to initiate a pivotal Phase ... <br/><font color="red">Devices, Oncology, FDA</font><br/><font color="blue">Medifocus, Microfocus, hyperthermia therapy, breast cancer</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030310</link>
			<pubDate>Tue, 09 Mar 2010 16:02:11 GMT</pubDate>
			<author><![CDATA[GeNO LLC]]></author>
		 <description><![CDATA[Stand-Alone Nitrosyl(TM) Delivery Platform to begin Phase 2 clinical trials

COCOA, Fla., March 9  (HSMN NewsFeed)  -- GeNO LLC (www.genollc.com) a privately held, advanced development-stage technology company, today announced that the U.S. Food and Drug... <br/><font color="red">Devices, Drug Delivery</font><br/><font color="blue">GeNO LLC, Nitrosyl Delivery Platform, nitric oxide</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Scivanta Medical Corporation Announces Results for Initial Clinical Trial for the Scivanta Cardiac Monitoring System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030309</link>
			<pubDate>Tue, 09 Mar 2010 15:58:06 GMT</pubDate>
			<author><![CDATA[Scivanta Medical]]></author>
		 <description><![CDATA[Initial Clinical Trial Results Meet Company's Expectations

SPRING LAKE, N.J., March 9  (HSMN NewsFeed)  -- Scivanta Medical Corporation (OTC Bulletin Board:SCVM.ob ), today announced that the results of its initial clinical trial for the Scivanta Cardia... <br/><font color="red">Devices, Cardiology, Monitoring</font><br/><font color="blue">Scivanta Medical, Cardiac Monitoring System</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Smith and Nephew Enhances Gold Standard Technique to Optimize Arthroscopic Repair of a Torn Meniscus]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030308</link>
			<pubDate>Tue, 09 Mar 2010 15:50:32 GMT</pubDate>
			<author><![CDATA[Smith & Nephew]]></author>
		 <description><![CDATA[Provides surgeons with easy implant deployment, speed, and superior fixation strength with minimal disruption to the meniscus

ANDOVER, Mass., March 9  (HSMN NewsFeed)  -- Smith & Nephew's (NYSE: SNN; LSE:SN) Endoscopy Division today announced the introd... <br/><font color="red">Devices, Orthopaedic, Surgery</font><br/><font color="blue">Smith & Nephew, FAST-FIX, Meniscal Repair, meniscus</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030307</link>
			<pubDate>Tue, 09 Mar 2010 15:46:36 GMT</pubDate>
			<author><![CDATA[Bristol-Myers Squibb]]></author>
		 <description><![CDATA[PRINCETON, N.J. & WILMINGTON, Del.--(HSMN NewsFeed)--Bristol-Myers Squibb Company (NYSE: BMY ) and AstraZeneca (NYSE: AZN ) today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” tr... <br/><font color="red">Biopharmaceuticals, Cardiology, Endocrinology</font><br/><font color="blue">Bristol-Myers Squibb, AstraZeneca, ONGLYZA, saxagliptin, diabetes</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Massachusetts Institute of Technology (MIT) to Launch New Brain Research Effort with Acquisition of Elekta MEG Technology]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030306</link>
			<pubDate>Tue, 09 Mar 2010 15:42:07 GMT</pubDate>
			<author><![CDATA[Elekta]]></author>
		 <description><![CDATA[Using magnetoencephalography (MEG), Elekta Neuromag system will help MIT researchers unlock mysteries of normal and abnormal brain function

CAMBRIDGE, Mass., March 9  (HSMN NewsFeed)  -- Researchers at MIT are eagerly anticipating the summer delivery of... <br/><font color="red">Devices, Neurology</font><br/><font color="blue">Elekta, Neuromag, magnetoencephalography</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[EDAP Receives Japanese Approval for Sonolith I-Sys]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030305</link>
			<pubDate>Tue, 09 Mar 2010 15:38:28 GMT</pubDate>
			<author><![CDATA[EDAP TMS]]></author>
		 <description><![CDATA[Enters Largest Global Lithotripsy Market

LYON, France, March 9, 2010 --(HSMN NewsFeed) -- EDAP TMS SA (Nasdaq:EDAP ), the global leader in therapeutic ultrasound, announced today that the Japanese Administration has granted marketing approval of its new... <br/><font color="red">Devices,  Urology, Regulatory</font><br/><font color="blue">EDAP TMS, ultrasound, Sonolith I-Sys, lithotripsy, ESWL</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030304</link>
			<pubDate>Tue, 09 Mar 2010 15:35:23 GMT</pubDate>
			<author><![CDATA[Teva Pharmaceutical]]></author>
		 <description><![CDATA[JERUSALEM--(HSMN NewsFeed)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA ) announced today that its Board of Directors received a letter from Mr. Eli Hurvitz indicating that he wishes to be released from his duties at Teva in order to focus on his ful... <br/><font color="red">Biopharmaceuticals, Generics, Personnel</font><br/><font color="blue">Teva Pharmaceutical</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030303</link>
			<pubDate>Tue, 09 Mar 2010 15:32:26 GMT</pubDate>
			<author><![CDATA[Aastrom Biosciences]]></author>
		 <description><![CDATA[Six-Month Interim Results in Study of Patients With Severe Cardiovascular Disease to be Presented Later This Year

ANN ARBOR, Mich., March 9, 2010 --(HSMN NewsFeed) -- Aastrom Biosciences, Inc. (Nasdaq:ASTMD ), a leading developer of autologous cellular ... <br/><font color="red">Regenerative Medicine, Cardiology</font><br/><font color="blue">Aastrom Biosciences, cardiomyopathy, heart failure, autologous cell, stem cell</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[ClearCount Medical Solutions Appoints David Haffner as CFO]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030302</link>
			<pubDate>Tue, 09 Mar 2010 15:28:58 GMT</pubDate>
			<author><![CDATA[ClearCount Medical Solutions]]></author>
		 <description><![CDATA[Experienced Medical Device CFO Brings Expertise to Growth Company

PITTSBURGH--(HSMN NewsFeed)--ClearCount Medical Solutions, an innovator of patient safety solutions for the operating room, today announced that it has appointed David Haffner as its Chie... <br/><font color="red">Devices, Surgery, Personnel</font><br/><font color="blue">ClearCount Medical Solutions, RFID, SmartSponge</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Still River Systems Selects RTI Software for Single-Room Proton Therapy System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030301</link>
			<pubDate>Tue, 09 Mar 2010 15:23:51 GMT</pubDate>
			<author><![CDATA[Real-Time Innovations]]></author>
		 <description><![CDATA[RTI Middleware Facilitates Dramatic Reduction in Size and Cost of Proton Therapy Systems

SUNNYVALE, Calif.--(HSMN NewsFeed)--Real-Time Innovations (RTI), The Real-Time Middleware Experts, today announced that Still River Systems has selected RTI Data Di... <br/><font color="red">Devices, Oncology</font><br/><font color="blue">Real-Time Innovations, Still River Systems, proton beam, radiotherapy</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Smith and Nephew Orthopaedics Eliminates Significant Radiation Exposure During Intramedullary Nail Cases]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030300</link>
			<pubDate>Tue, 09 Mar 2010 15:21:04 GMT</pubDate>
			<author><![CDATA[Smith & Nephew]]></author>
		 <description><![CDATA[New TRIGEN(TM) SURESHOT(TM) Distal Targeting System Provides Real-Time Visualization for Guiding Distal Screw Placement Without the Use of Fluoroscopy

MEMPHIS, Tenn. March 9  (HSMN NewsFeed)  -- Smith & Nephew (NYSE: SNN; LSE: SN) Orthopaedics Division ... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">Smith & Nephew, TRIGEN , SURESHOT, Distal Targeting System</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[CONMED Corporation Launches New Products at Annual American Academy of Orthopaedic Surgeons Meeting]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030299</link>
			<pubDate>Tue, 09 Mar 2010 15:15:29 GMT</pubDate>
			<author><![CDATA[CONMED]]></author>
		 <description><![CDATA[UTICA, NY - (HSMN NewsFeed) - CONMED Corporation (NASDAQ:CNMD ) today announced that its CONMED Linvatec business unit will formally launch five new medical devices in its Sports Medicine and Capital product lines at the Annual Meeting of the American Acad... <br/><font color="red">Devices, Orthopaedic, Surgery</font><br/><font color="blue">CONMED, Bioabsorbable Suture Anchor, Shaver, Oscillating Saw</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Newly Published Data Shows Chronix Biomedical's Serum DNA Assays Can Detect Early-Stage Breast Cancer]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030298</link>
			<pubDate>Tue, 09 Mar 2010 14:52:51 GMT</pubDate>
			<author><![CDATA[Chronix Biomedical]]></author>
		 <description><![CDATA[Study in Molecular Cancer Research Shows Utility of Chronix’s Technology for Screening for Undiagnosed Breast Cancer and Monitoring of Cancer Recurrence

SAN JOSE, Calif.--(HSMN NewsFeed)--Chronix Biomedical today announced publication of a study that su... <br/><font color="red">Diagnostics, Oncology</font><br/><font color="blue">Chronix Biomedical, serum DNA, circulating DNA, breast cancer</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Human Genome Sciences Appoints David P. Southwell Executive Vice President and Chief Financial Officer]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030297</link>
			<pubDate>Tue, 09 Mar 2010 14:50:14 GMT</pubDate>
			<author><![CDATA[Human Genome Sciences]]></author>
		 <description><![CDATA[ROCKVILLE, Md.--(HSMN NewsFeed)--Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced that David P. Southwell has been named Executive Vice President and Chief Financial Officer. He will report directly to H. Thomas Watkins, President and Chief Exec... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue">Human Genome Sciences</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Integra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030296</link>
			<pubDate>Tue, 09 Mar 2010 14:47:58 GMT</pubDate>
			<author><![CDATA[Integra LifeSciences]]></author>
		 <description><![CDATA[PLAINSBORO, N.J., March 9, 2010 --(HSMN NewsFeed) -- Integra Lifesciences Holdings Corporation (Nasdaq:IART ) announced today that it has created a portfolio of advanced bone grafting products, which will be sold in conjunction with its Integra Spine impla... <br/><font color="red">Devices, Orthopaedic, Neurosurgery</font><br/><font color="blue">Integra LifeSciences, OsteoSparx, OsteoSurge, OsteoStrux</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030295</link>
			<pubDate>Tue, 09 Mar 2010 14:44:28 GMT</pubDate>
			<author><![CDATA[INSYS Therapeutics]]></author>
		 <description><![CDATA[Unique delivery method achieves statistical significance in five minutes

PHOENIX, March 9  (HSMN NewsFeed)  -- INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual S... <br/><font color="red">Biopharmaceuticals, Drug Delivery</font><br/><font color="blue">INSYS Therapeutics, Fentanyl, Sublingual Spray</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Varian Medical Systems Names Dr. John Adler as Chief of New Clinical Applications]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030294</link>
			<pubDate>Tue, 09 Mar 2010 04:02:43 GMT</pubDate>
			<author><![CDATA[Varian Medical Systems]]></author>
		 <description><![CDATA[PALO ALTO, Calif., March 8  (HSMN NewsFeed)  -- Varian Medical Systems (NYSE:VAR ) today announced that it has appointed John R. Adler, Jr., M.D., as Vice President and Chief of New Clinical Applications for the company.  Dr. Adler, a renowned neurosurgeon... <br/><font color="red">Devices, Oncology, Neurosurgery, Personnel</font><br/><font color="blue">Varian Medical Systems, Accuray, radiotherapy, radiosurgery</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030293</link>
			<pubDate>Tue, 09 Mar 2010 00:21:05 GMT</pubDate>
			<author><![CDATA[X-spine Systems]]></author>
		 <description><![CDATA[MIAMISBURG, Ohio--(HSMN NewsFeed)--X-spine Systems, Inc., a global manufacturer of implants and instruments for spinal surgery, announced today that it has entered into an exclusive license agreement with Gamma Spine for the development and distribution of... <br/><font color="red">Devices, Orthopaedic, Neurosurgery, Licensing</font><br/><font color="blue">X-spine Systems, Gamma Spine</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Bioness Appoints New President and CEO]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030292</link>
			<pubDate>Tue, 09 Mar 2010 00:19:03 GMT</pubDate>
			<author><![CDATA[Bioness]]></author>
		 <description><![CDATA[VALENCIA, Calif.--(HSMN NewsFeed)--Bioness Inc. announces that its Board of Directors named Thomas G. Fogarty as the company’s new President and CEO, effective February 4th. Fogarty succeeds former President and CEO Yitzhak Zilberman, who has left the comp... <br/><font color="red">Devices, Neurology, Personnel</font><br/><font color="blue">Bioness, Neuromodulation, Foot Drop</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030291</link>
			<pubDate>Tue, 09 Mar 2010 00:15:03 GMT</pubDate>
			<author><![CDATA[Omthera Pharmaceuticals]]></author>
		 <description><![CDATA[Dyslipidemia Experts Jerry Wisler and Michael Davidson, M.D. Co-Found New Pharmaceutical Company Developing a Prescription Omega 3 Treatment of High Triglycerides

NEW YORK--(HSMN NewsFeed)--Omthera Pharmaceuticals, Inc., an emerging specialty pharmaceut... <br/><font color="red">Biopharmaceuticals, Cardiology, Venture Capital</font><br/><font color="blue">Omthera Pharmaceuticals, Epanova, triglycerides, dyslipidemia</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Orthofix International Sells Vascular Business to Covidien]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030290</link>
			<pubDate>Tue, 09 Mar 2010 00:01:37 GMT</pubDate>
			<author><![CDATA[Orthofix]]></author>
		 <description><![CDATA[BOSTON--(HSMN NewsFeed)--Orthofix International N.V. (NASDAQ: OFIX ) (the Company) announced today it has sold the assets of its vascular business, including its AV-Impulse&reg; mechanical compression technology, to Covidien.

“This transaction represent... <br/><font color="red">Devices, Acquisitions</font><br/><font color="blue">Orthofix, Covidien, AV-Impulse</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[NxStage Announces New FREEDOM Data Showing the Positive Impact of its Daily Home Hemodialysis Therapy on Sleep Quality and Restless Legs Syndrome]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030288</link>
			<pubDate>Mon, 08 Mar 2010 15:27:02 GMT</pubDate>
			<author><![CDATA[NxStage Medical]]></author>
		 <description><![CDATA[LAWRENCE, Mass. and SEATTLE, March 8  (HSMN NewsFeed)  -- Booths # 23-25 at the Annual Dialysis Conference -- NxStage Medical, Inc. (Nasdaq:NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ... <br/><font color="red">Devices</font><br/><font color="blue">NxStage Medical, home hemodialysis, hemodialysis, Restless Legs Syndrome</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030287</link>
			<pubDate>Mon, 08 Mar 2010 12:54:02 GMT</pubDate>
			<author><![CDATA[Afraxis]]></author>
		 <description><![CDATA[David Campbell, Ph.D., will Head Development of Drugs for Central Nervous System Disorders

Carmine Stengone will Lead Business Development Efforts

SAN DIEGO, March 8  (HSMN NewsFeed)  -- Afraxis, a San Diego-based biotechnology company developing dru... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue">Afraxis</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Ascension Orthopedics Introduces the PyroTITAN(TM) Humeral Resurfacing Arthroplasty System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030286</link>
			<pubDate>Mon, 08 Mar 2010 12:50:49 GMT</pubDate>
			<author><![CDATA[Ascension Orthopedics]]></author>
		 <description><![CDATA[AUSTIN, Texas, March 8  (HSMN NewsFeed)  -- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic S... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">Ascension Orthopedics, PyroTITAN, Humeral Resurfacing Arthroplasty, PyroCarbon</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[ThermalTherapeutic Systems Announces FDA Clearance of the VERATHERM(TM) Portable Hyperthermic Perfusion System]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030285</link>
			<pubDate>Mon, 08 Mar 2010 12:46:16 GMT</pubDate>
			<author><![CDATA[ThermalTherapeutic Systems]]></author>
		 <description><![CDATA[PITTSBURGH, March 8  (HSMN NewsFeed)  -- ThermalTherapeutic Systems, Inc. today announced that the FDA has cleared the company to market its VERATHERM™ Portable Hyperthermic Perfusion System effective immediately. 

&quot;FDA clearance is a significant a... <br/><font color="red">Devices, FDA</font><br/><font color="blue">ThermalTherapeutic Systems, VERATHERM, Hyperthermic Perfusion</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Auxilium Announces Availability of XIAFLEX(TM) for the Treatment of Dupuytren's Contracture]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030284</link>
			<pubDate>Mon, 08 Mar 2010 12:42:27 GMT</pubDate>
			<author><![CDATA[Auxilium Pharmaceuticals]]></author>
		 <description><![CDATA[MALVERN, PA--(HSMN NewsFeed) - Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL ), a specialty biopharmaceutical company, today announced that XIAFLEX™ (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, is now availabl... <br/><font color="red">Biopharmaceuticals</font><br/><font color="blue">Auxilium Pharmaceuticals, XIAFLEX, Dupuytren's contracture</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Osteotech's MagniFuse(TM) Distributed to 68 U.S. Hospitals as Product Revenue Surpasses $1 Million]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030283</link>
			<pubDate>Mon, 08 Mar 2010 12:36:48 GMT</pubDate>
			<author><![CDATA[Osteotech]]></author>
		 <description><![CDATA[National Launch on Target to begin in Second Quarter 2010

EATONTOWN, N.J., March 8  (HSMN NewsFeed)  -- Osteotech, Inc. (Nasdaq:OSTE ), a leader in the emerging field of biologic products for regenerative healing, announced today that its MagniFuse™ Bon... <br/><font color="red">Regenerative Medicine</font><br/><font color="blue">Osteotech, MagniFuse, Bone Graft</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[KCI Announces Reimbursement Approval in Japan]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030282</link>
			<pubDate>Mon, 08 Mar 2010 12:28:25 GMT</pubDate>
			<author><![CDATA[Kinetic Concepts]]></author>
		 <description><![CDATA[Reimbursement Clears Way to Commercialize KCI’s Revolutionary V.A.C.&reg; Therapy System in Japan

SAN ANTONIO--(HSMN NewsFeed)--Kinetic Concepts, Inc. (NYSE: KCI ) today announced it has received reimbursement approval from Japan’s Health Insurance Bure... <br/><font color="red">Devices, Wound Care, Reimbursement</font><br/><font color="blue">Kinetic Concepts, V.A.C. ATS, V.A.C. Therapy, Negative Pressure Wound Therapy</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030281</link>
			<pubDate>Mon, 08 Mar 2010 12:23:02 GMT</pubDate>
			<author><![CDATA[EUSA Pharma]]></author>
		 <description><![CDATA[EUSA Presence Established in Over 80 Countries

Company Positioned for Strong Growth and Profitability in 2010

OXFORD, England and LANGHORNE, Pennsylvania, March 8, 2010  (HSMN NewsFeed)  -- EUSA Pharma ('EUSA'), a transatlantic specialty pharmaceutic... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue">EUSA Pharma</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[MedShape Solutions, Inc. Announces Commercialization of SBIR-funded Technology:   Receives Purchasing Preference in Federally-funded Hospitals and Healthcare Facilities]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030289</link>
			<pubDate>Sat, 06 Mar 2010 04:00:00 GMT</pubDate>
			<author><![CDATA[MedShape Solutions]]></author>
		 <description><![CDATA[ATLANTA, March 5, 2010 - (HSMN NewsFeed) -  MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPH... <br/><font color="red">Devices, Orthopaedic</font><br/><font color="blue">MedShape Solutions, MORPHIX, Shape Memory Suture Anchor</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[XenoPort Restructures to Focus on Key Programs]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030280</link>
			<pubDate>Fri, 05 Mar 2010 18:42:13 GMT</pubDate>
			<author><![CDATA[XenoPort]]></author>
		 <description><![CDATA[SANTA CLARA, Calif.--(HSMN NewsFeed)--XenoPort, Inc. (Nasdaq:XNPT ) announced today a restructuring that includes an overall reduction in its workforce of approximately 50%. The restructuring is designed to focus the Company’s resources on advancement of i... <br/><font color="red">Biopharmaceuticals</font><br/><font color="blue">XenoPort, Horizant, gabapentin, restless legs syndrome</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030279</link>
			<pubDate>Fri, 05 Mar 2010 18:36:46 GMT</pubDate>
			<author><![CDATA[EDAP TMS]]></author>
		 <description><![CDATA[Session Emphasizes Attractiveness of Ablatherm-HIFU in Focal Therapy

LYON, France, March 5, 2010 --(HSMN NewsFeed) -- EDAP TMS SA (Nasdaq:EDAP ), the global leader in therapeutic ultrasound, reported today its successful participation at the Third Inter... <br/><font color="red">Devices, Oncology</font><br/><font color="blue">EDAP TMS, Ablatherm, HIFU, prostate cancer</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030278</link>
			<pubDate>Fri, 05 Mar 2010 15:23:58 GMT</pubDate>
			<author><![CDATA[Stentys]]></author>
		 <description><![CDATA[PRINCETON, N.J. & PARIS--(HSMN NewsFeed)--Medical device pioneer Stentys announced today that it has received CE Marking for its self-expanding and disconnectable stent to treat acute coronary syndrome (ACS).

The self-expanding feature of the Stentys pl... <br/><font color="red">Devices, Interventional Cardiology, Regulatory</font><br/><font color="blue">Stentys, self-expanding stent, acute coronary syndrome, coronary stent</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030277</link>
			<pubDate>Fri, 05 Mar 2010 15:17:26 GMT</pubDate>
			<author><![CDATA[La Jolla Pharmaceutical]]></author>
		 <description><![CDATA[SAN DIEGO--(HSMN NewsFeed)--La Jolla Pharmaceutical Company (Pink Sheets: LJPC ) today announced that La Jolla and Adamis Pharmaceuticals Corporation (OTCBB: ADMP ) have agreed to terminate their merger agreement relating to the proposed merger of the two ... <br/><font color="red">Biopharmaceuticals, Mergers & Acquisitions</font><br/><font color="blue">La Jolla Pharmaceutical, Adamis Pharmaceuticals</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Saladax Biomedical Closes $8 Million Series C Financing]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030275</link>
			<pubDate>Fri, 05 Mar 2010 14:57:10 GMT</pubDate>
			<author><![CDATA[Saladax Biomedical]]></author>
		 <description><![CDATA[Accelerates Development of Personalized Patient Dosing for Cancer and CNS Disorders

BETHLEHEM, Pa.--(HSMN NewsFeed)--Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Bos... <br/><font color="red">Personalized Medicine, Diagnostics, Venture Capital</font><br/><font color="blue">Saladax Biomedical, MYCARE</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Aureon Laboratories Announces Name Change for Existing Post-Surgical Prostate Cancer Recurrence Test]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030274</link>
			<pubDate>Fri, 05 Mar 2010 14:53:31 GMT</pubDate>
			<author><![CDATA[Aureon Laboratories]]></author>
		 <description><![CDATA[Commercially Available Since February 2006, Post-Op Px(TM) is the First Diagnostic Test to Predict Prostate Cancer Recurrence

YONKERS, N.Y., March 5, 2010 --(HSMN NewsFeed) -- Today, Aureon Laboratories, Inc. announced a new name for its post-prostatect... <br/><font color="red">Diagnostics, Oncology</font><br/><font color="blue">Aureon Laboratories, Post-Op Px, prostate cancer</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Levia(R) Brings Personal Targeted Phototherapy Home as a Treatment Option for Millions of Psoriasis Patients]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030273</link>
			<pubDate>Fri, 05 Mar 2010 14:50:44 GMT</pubDate>
			<author><![CDATA[Lerner Medical Devices]]></author>
		 <description><![CDATA[LOS ANGELES, CA - (HSMN NewsFeed) - Lerner Medical Devices, Inc. (LMD) today introduced Levia, an innovative medical device providing Personal Targeted Phototherapy™ with Ultraviolet B (UVB) light -- a safe and effective non-drug option for the self-treatm... <br/><font color="red">Devices, Dermatology</font><br/><font color="blue">Lerner Medical Devices, Levia , phototherapy, psoriasis</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[SurModics Announces Organizational and Leadership Changes]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030276</link>
			<pubDate>Fri, 05 Mar 2010 04:00:00 GMT</pubDate>
			<author><![CDATA[SurModics]]></author>
		 <description><![CDATA[EDEN PRAIRIE, Minn., Mar 04, 2010 (HSMN NewsFeed) -- SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today certain organizational and leadership changes designe... <br/><font color="red">Devices, Personnel</font><br/><font color="blue">SurModics</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[iBio Appoints Vidadi Yusibov, Ph.D. Chief Scientific Officer]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030272</link>
			<pubDate>Thu, 04 Mar 2010 16:46:00 GMT</pubDate>
			<author><![CDATA[iBio, Inc.]]></author>
		 <description><![CDATA[NEWARK, Del.--(HSMN NewsFeed)--iBio, Inc. (OTCBB:IBPM ) announced today the appointment of Vidadi Yusibov, Ph.D. as Chief Scientific Officer. Dr. Yusibov is the Executive Director of the Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, De... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue"> iBio , iBioLaunch</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[IVAX Diagnostics' Diamedix Subsidiary Signs Three Year Exclusive Distribution Agreement with Fumouze Diagnostics]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030271</link>
			<pubDate>Thu, 04 Mar 2010 13:23:17 GMT</pubDate>
			<author><![CDATA[IVAX Diagnostics]]></author>
		 <description><![CDATA[Increases European Footprint To Include France

MIAMI--(HSMN NewsFeed)--IVAX Diagnostics, Inc. (AMEX: IVD ), a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diag... <br/><font color="red">Diagnostics, Distribution</font><br/><font color="blue">IVAX Diagnostics, Diamedix, Fumouze Diagnostics, Delta Biologicals</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030270</link>
			<pubDate>Thu, 04 Mar 2010 13:19:47 GMT</pubDate>
			<author><![CDATA[Watson Pharmaceuticals]]></author>
		 <description><![CDATA[Established, patient-preferred infertility treatment

Expands Watson's Women's Health brand product portfolio

Preterm birth clinical trials currently underway

Company acquires 11.2 million shares of Columbia common stock

MORRISTOWN, N.J., March ... <br/><font color="red">Biopharmaceuticals, Acquisitions</font><br/><font color="blue">Watson Pharmaceuticals, Columbia Laboratories, CRINONE, PROCHIEVE</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Freedom Driver System Receives CE Mark to Power SynCardia's Total Artificial Heart in Europe]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030269</link>
			<pubDate>Thu, 04 Mar 2010 13:14:29 GMT</pubDate>
			<author><![CDATA[SynCardia Systems]]></author>
		 <description><![CDATA[1st Wearable Portable Driver Allows Stable European Patients to Enjoy Quality Lifestyle at Home While They Wait for a Matching Donor Heart

TUCSON, Ariz.--(HSMN NewsFeed)--On March 4, SynCardia Systems, Inc., manufacturer of the SynCardia temporary Cardi... <br/><font color="red">Devices, Cardiology, Regulatory</font><br/><font color="blue">SynCardia Systems, CardioWest, Total Artificial Heart, Freedom driver</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Covidien Announces Preferred Vendor Partnership with OSF Healthcare System for Nellcor OxiMax Pulse Oximetry Products]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030268</link>
			<pubDate>Thu, 04 Mar 2010 04:45:22 GMT</pubDate>
			<author><![CDATA[Covidien]]></author>
		 <description><![CDATA[Seven-hospital multistate system serves more than 2.5 million patients a year

BOULDER, Colo.--(HSMN NewsFeed)--Covidien (NYSE: COV ), a leading global provider of healthcare products and recognized innovator of mechanical ventilation and respiratory car... <br/><font color="red">Devices, Monitoring, Group Purchasing</font><br/><font color="blue">Covidien, Nellcor, OxiMax, pulse oximetry</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[EKR Therapeutics Appoints John Bailye as Interim President and Chief Executive Officer]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030267</link>
			<pubDate>Thu, 04 Mar 2010 01:25:24 GMT</pubDate>
			<author><![CDATA[EKR Therapeutics]]></author>
		 <description><![CDATA[BEDMINSTER, N.J.--(HSMN NewsFeed)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that its Executive Chairman John Bailye has been appointed Interim President and Chief Ex... <br/><font color="red">Biopharmaceuticals, Personnel</font><br/><font color="blue">EKR Therapeutics</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[AGA Medical Announces Promotion of Three Senior Executives]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030266</link>
			<pubDate>Thu, 04 Mar 2010 01:23:12 GMT</pubDate>
			<author><![CDATA[AGA Medical]]></author>
		 <description><![CDATA[Jack Darby Named Senior Vice President, Global Marketing and Distributor Sales;

Don O’Hearn Named Senior Vice President, Americas;

Gianluca Iasci Named Senior Vice President, Europe, Middle East and Africa

MINNEAPOLIS--(HSMN NewsFeed)--AGA Medical... <br/><font color="red">Devices, Personnel</font><br/><font color="blue">AGA Medical</font>]]>
			</description>
	</item>
	<item>
		 <title><![CDATA[Geron Highlights Product Launch from Collaboration with Corning - the Synthemax Surface for Scalable Growth of Human Embryonic Stem Cells]]></title>
			<link>http://salesandmarketingnetwork.com/news_release.php?ID=2030265</link>
			<pubDate>Wed, 03 Mar 2010 21:50:45 GMT</pubDate>
			<author><![CDATA[Geron Corp]]></author>
		 <description><![CDATA[MENLO PARK, Calif.--(HSMN NewsFeed)--Geron Corporation (Nasdaq:GERN ) today announced that Corning Incorporated (NYSE:GLW ) has launched the Synthemax™ surface, a new synthetic matrix for growing human embryonic stem cells (hESCs), developed under a collab... <br/><font color="red">Regenerative Medicine</font><br/><font color="blue">Geron Corp, Corning, Synthemax, stem cell</font>]]>
			</description>
	</item>
	</channel>
</rss>